|
NGNE Neurogene Inc 1404644 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-30,934,000.00 |
| Balance Sheet |
|
Current Assets
|
$246,747,000.00 |
|
Assets
|
$263,141,000.00 |
|
Current Liabilities
|
$18,866,000.00 |
|
Liabilities
|
$25,358,000.00 |
|
Equity
|
$237,783,000.00 |
|
Shares Out
|
15615786.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-26,119,000.00 |
|
Investing Cash Flow
|
$46,240,000.00 |
| Market Analysis |
Market Cap
|
$524,690,409.60 |
|
Price
|
$32.69 |
|
BVPS
|
15.23 |
|
PB
|
2.21 |
|
EPS
|
-1.39 |
|
FCF
|
$-26,400,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:26 |
|
| Apr |
May |
Jun |
| 2026-03-24 |
-4.24 |
|
|
2026-05-12 |
-1.39 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-1.05 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.99 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NGNE documents filed with the SEC.
NGNE Filings
Clear
